Skip to main content
# Title Department Research Year
201 Design and Synthesis of Novel 1,3,4-Oxadiazole and 1,2,4-Triazole Derivatives as Cyclooxygenase-2 Inhibitors with Anti-inflammatory and Antioxidant activity in LPS-stimulated RAW264.7 Macrophages Department of Medicinal Chemistry 2022
202 Interplay of biochemical, genetic, and immunohistochemical factors in the etio-pathogenesis of gastric ulcer in rats: a comparative study of the effect of pomegranate loaded nanoparticles versus pomegranate peel extract 2021
203 Studying the Complex Formation of Sulfonatocalix[4]naphthalene and Meloxicam towards Enhancing Its Solubility and Dissolution Performance Department of Industrial Pharmacy 2021
204 Untargeted Analysis of Lemna minor Metabolites: Workflow and Prioritization Strategy Comparing Highly Confident Features between Different Mass Spectrometers Department of Pharmacognosy 2021
205 A bio-analytically validated HPLC-UV method for simultaneous determination of doripenem and ertapenem in pharmaceutical dosage forms and human plasma: a dual carbapenem regimen for treatment of drug-resistant strain of Klebsiella pneumoniae Department of Pharmaceutical Analytical Chemistry 2021
206 Inversion Kinetics of Some E/Z 3-(Benzylidene)-2-Oxo-indoline Derivatives and Their In Silico CDK2 Docking Studies Department of Medicinal Chemistry 2021
207 Innovative computationally designed-spectrofluorimetric method for determination of modafinil in tablets and human plasma Department of Pharmaceutical Analytical Chemistry 2021
208 Indirect Differential Pulse Voltammetric Determination of Fluoride Ions at Carbon Paste Electrode Modified with Porous and Electroactive Fe3+/Fe2+ Based-Metal Organic Frameworks Type MIL-101(Fe) Department of Pharmaceutical Analytical Chemistry 2021
209 Towards understanding of the interaction of certain carbapenems with protein via combined experimental and theoretical approach Department of Pharmaceutical Analytical Chemistry 2021
210 Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile Department of Pharmaceutical Organic Chemistry 2021